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Abstract
Aim: Due to inadequate data on the dynamics of foot and mouth disease (FMD) infection in buffalo, the present work was 
aimed at investigating some virological and immunological aspects of FMD virus (FMDV) SAT2 infection in naturally 
exposed and vaccinated buffalo cows and their calves.
Materials and Methods: The study employed clinical observation and examination, virus isolation in mice and cell culture, 
in addition to virus detection using complement fixation test; indirect sandwitch enzyme-linked immunosorbent assay and 
demonstration of RNA by reverse transcription polymerase chain reaction for confirmation the results.
Results: FMD type SAT2 antibodies was detected in a protective level by the 1st week post infection and 3rd week post 
vaccination and peak titers were recorded by the 3rd week, 12th week in infected and vaccinated buffaloes, respectively. 
These titers began to decline to reach their lowest protective levels by the 36th week, 12nd week in infected and vaccinated 
buffaloes respectively. The SAT2 antibodies in calves born to vaccinated and infected buffalo cows were detected on 
the 1st day post parturation through the suckling of their Dam’s colostrums. The highest maternal antibody titers were 
recorded in sera by the 2nd day post parturation. These antibodies declined gradually to reach their lowest protective levels 
on 14th week, 16th week post parturition in calves from vaccinated and infected buffaloes, respectively. High antibody titers 
in the colostrums and milk of vaccinated and naturally infected buffalo cows were recorded at parturition, and they began to 
decrease gradually recording their lowest protective titers by 10th and 12nd week post parturition respectively.
Conclusion: FMDV serotype SAT2 was confirmed as a causative agent of the suspected FMD signs in pregnant buffalo 
at El-Fayoum Governorate, Egypt, during 2012. Vaccinated and naturally infected buffalo cows were able to provide their 
calves with high levels of maternal derived antibodies through their colostrums, which could protect new born calves for 
not less than 14 week post parturation.
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Introduction
Foot and mouth disease (FMD) is an infectious 
disease of cattle, buffalo, sheep, goats, pigs and also 
wild cloven hoofed animals. FMD virus (FMDV) is 
the cause of the disease. The virus has seven serolog-
ical types, identified as; O, A, C, SAT1, SAT2, SAT3 
and Asia1 [1,2]. FMD is characterized by fever, lame-
ness and vesicular lesions on the feet, tongue, snout 
and teats, with high morbidity and low mortality [3].
The disease is enzootic in Egypt, with many out-
breaks having been reported since 1950. The present 
serotypes in Egypt now are FMD serotypes SAT2, A 
and O. Serotype O was reported by Aidaros [4-6] sero-
type A was firstly recorded in Egypt in 2006 through 
importation of live animals, and resulted in sever 
clinical signs in cattle and buffaloes [7]. The recent 
introduction involved serotype SAT2 in 2012, also 
from the importation of live animals. All these FMDV 
serotypes were isolated and typed by Veterinary 
Serum and Vaccine Research Institute (VSVRI) and 
confirmed by World Reference Laboratory (WRL) for 
FMD, Pirbright Institute, United Kingdom [8].
The FMD serotype SAT2 outbreaks in Egypt 
were officially reported by the OIE on 14 March 2012. 
Thirteen outbreaks were recorded in 8 out of 27 gov-
ernorates mainly in the delta area and few along the 
Nile in the southern parts of the country. The affected 
species include cattle and buffalo, where young buf-
faloes appeared to be the category of animals more 
severely affected, mortalities in young stock may be 
high as a result of lack of maternal immunity, live-
stock census data in Egypt estimate 6.3 million heads 
of buffalo and cattle in addition to 7.5 million heads of 
small ruminants are at risk [9].
FMDV can be isolated from infected tongue 
epithelium and esopharyngeal fluid by intrapretonial 
inoculation of baby mice, where paralysis of the hind 
limbs of all inoculated mice would suggest positive 
isolation. Virus identification and serotyping can be 
done by indirect sandwich enzyme linked immunosor-
bent assay (ELISA) [10].
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Cattle naturally infected with FMDV showed 
a rapid rise in serum antibody immunoglobulin G1 
which can be detected between 7 and 10 days post 
infection and is highly serotype specific. The antibody 
titers normally reach a peak at 28 days post infection 
and remain at protective level for months [11]. The 
antibody response in cattle experimentally infected 
with FMDV serotype (O) lasts for approximately 
40 weeks, and the highest antibody titer were reached 
at 10 weeks post infection [12]. Nonetheless it was 
concluded that neutralizing antibodies remained for 
18 months in FMDV serotype O experimentally 
infected cattle, where the serum neutralizing antibod-
ies reached their highest titers within 7-10 days post 
infection. The antibody levels remained protective for 
4 months, and virus could be isolated from the esopha-
ryngeal fluid (OP) for up to 4 weeks post inoculation 
(carrier for the virus) [13].
The control strategy used for FMD in Egypt 
depends on the use of bivalent serotype O, A oil based 
ISA 206 inactivated vaccine in combination with the 
recently formulated monovalent serotype SAT2 oil 
inactivated one. Typing of outbreak virus is regarded 
as a necessary adjunct to disease control to determine 
the causative agent and prepare vaccine against it [14].
The vaccination of new born calves from dams 
vaccinated in late pregnancy must be performed when 
they are over 3 months of age, while those born to 
non-vaccinated dams can be vaccinated during the 
1st month post parturation [15].
The mean colostrum antibody titers were reported 
to be higher than serum antibody titers in ewes at par-
turition when vaccinated with FMD (O) inactivated 
vaccine [16,17]. Also found that antibody titers in sera 
of kids born to goats vaccinated with FMD vaccine at 
3 months of pregnancy were high in day old kids after 
feeding on colostrum and remained at a protective lev-
els from 45 to 60 day after birth. Mentioned that FMD 
antibody titers in colostrum and milk from experimen-
tally infected pregnant ewes were high on the 1st day 
post parturation with mean titers of 2.52 and 2.82 log10 
by serum neutralization test (SNT) and ELISA respec-
tively [18]. The antibody titers decreased gradually to 
1.26 and 1.56 log10 by SNT and ELISA respectively, 
by the 11th week. By the 16th week post partum, only 
traces of FMDV antibodies remained in milk.
The mean protective serum antibody titers 
against FMDV serotypes O and A in calves vacci-
nated with double oil emulsion (Montanide ISA 206) 
as evaluated by ELISA and SNT were observed on 
the 3rd week post vaccination and reached the high-
est level on the 10th week, and continued at protective 
levels until the 32nd week post vaccination, and then 
started to decline below protective level [19,20].
There is a paucity of information on FMDV 
infection in buffalo, and the current study was aimed 
at investigating the virological and immunological 
aspects FMDV type SAT2 in Egyptian buffalo cows 
and their calves.
Materials and Methods
Ethical approval
The experiment was carried out according to the 
protocol of Institutional Animal Ethics Committee 
and the authors had a permission of the animal owners 
at the private farms.
Animals
Buffaloes
A total of 150 buffalo cows from two farms, A 
and B, constituted the study.
Farm (A) was a private farm at El-Fayoum 
Governorate and consisted of 50 pregnant animals which 
were naturally infected with SAT2/FMDV during the 2012.
Farm (B) was a private farm at El-Fayoum 
Governorate and consisted of 100 clinically healthy 
pregnant buffalos which free from FMD type SAT2/
Egypt/2012 antibodies when screened by serum neu-
tralization test and indirect ELISA. These animals 
were divided into two groups, group one contain 90 
pregnant buffalos vaccinated with FMD type SAT2 
monovalent oil vaccine and 10 pregnant buffalos non 
vaccinated kept as negative control.
Suckling baby mice
Fifty, 2-4 days old, suckling Swiss Albino mice 
were supplied from Veterinary Serum and Vaccine 
Research Institute (VSVRI), Abassia - Cairo. The 
mice were used for isolation of FMDV through the 
intraperitoneal inoculations (I/P).
FMDV
Locally isolated FMDV (FMDV/SAT2/Egypt/2012) 
of cattle origin was typed and sub-typed at the FMD 
Department VSVRI, Abbasia, Cairo and confirmed by 
WRL for FMD, Pirbright Institute, United Kingdom was 
used in the study. The virus was adapted to baby ham-
ster kidney (BHK) cell culture and used in serum neutral-
ization test and preparation of virus antigen for ELISA. 
Storage was at −70°C until further use.
Cell culture
BHK21cell line clone 13 maintained at the FMD 
Department, VSVRI Abbasia, Cairo, using Eagl’s 
medium with 8-10% bovine serum as described by 
Xuan et al. [21], was used for application of serum 
neutralization test and vaccine preparation.
Vaccine
Locally produced inactivated monovalent FMD 
vaccine (FMDV/SAT2/Egypt/2012) adjuvanted with 
Montanide ISA 206 oil was supplied by VSVRI for 
vaccination of buffalo cows in farm B.
Samples
Serum
Sera collected from the following sources were 
utilized in the study:
1. 50 pregnant and naturally infected buffalos at the
time of clinical signs appearance (zero time) then
weekly to 4 weeks, every 2 weeks to 12 weeks
then every 4 weeks to the end of experiment.Available at www.veterinaryworld.org/Vol.7/October-2014/25.pdf
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2. 50 buffalo calves born to the naturally infected
cow, from calving till 20 weeks.
3. 90 vaccinated and 10 non vaccinated buffalos
before vaccination weekly to 4 weeks, every
2 weeks to 12 weeks then every 4 weeks to the
end of experiment
4. 90 buffalo calves from calving till 20 weeks and
10 calves from control buffalo.
Tongue epithelial
Two grams of tongue epithelial tissues were 
ground using sterile sand with pestle and mortar. 
Veronal buffer (8 ml) was added to the homogenized 
tissues, and chloroform added to the mixture, followed 
by centrifugation at 7000 rpm for 10 min at 4°C. The 
supernatant was collected and tested for FMDV pres-
ence in tissue culture and mice [10].
Oesopharyngeal fluid
The esopharyngeal scraping were collected 
by means of a probang sampling cup with a slightly 
sharpened edge [22]. Each sample was treated with 
chloroform and centrifuged at 7000 rpm for 10 min, 
and the supernatant was stored at −70°C until used for 
FMDV isolation.
Colostrum and milk
1. Colostrum samples collected from 50 pregnant
naturally infected buffalo at the time of partura-
tion (zero time), 1, 2, 3, 4 day post parturation
then the milk samples were collected weekly for
14 weeks post parturition.
2. Colostrum samples collected from 90 pregnant
vaccinated and 10 pregnant control buffalo at the
time of parturition (zero time), 1, 2, 3, 4 day post
parturation then the milk samples were collected
weekly for 14 weeks.
The samples were treated with renin and whey 
stored at −20°C until the antibody detected with SNT 
and ELISA.
Laboratory tests
Virus isolation
In tissue culture
It was done as described by Mansour [23] where 
serial ten folds dilutions of FMDV were prepared in 
tissue culture plates using Hank’s solution, 50 μl/well, 
from each dilution a set of 4 wells were inoculated 
on BHK cells, control non-infected cells were inoc-
ulated with 50 μl of Hank’s solution then the plate 
was incubated at 37°C for 18-24 hours and observed 
for the cytopathic effect [CPE] and compared with 
the control non-infected cells. Finally the titer was 
expressed as log10 TCID50 as described by Reed and 
Muench [24].
In mice
50 baby mice of about 2-4 days old were used 
for virus titration. Serial 10-folds dilutions in Hank’s 
solution were prepared from the virus to be titrated. 
For each dilution a group of 8 mice were injected 
with 0.1 ml intraperitonially. Mice deaths or symp-
toms were recorded till the 5th-7th day post inoculation 
according to Mahy and Kangaro [25].
Antigen detection
Complement fixation test (CFT)
The test was used for typing of the FMDV iso-
lates obtained from samples from naturally infected 
buffalo cow using protocols described by Alonso 
et al. [26,27]. Guinea pig hyper immune sera against 
seven FMDV serotypes, were supplied by WRL for 
FMD in Pirbright Institute, United Kingdom.
Indirect sandwich ELISA
Virus typing results were confirmed by indi-
rect sandwich ELISA kit provided by the FMD WRL 
(WRL-Pirbright, UK) [8].
Coating
ELISA plates were coated by addition of 50 μl 
of rabbit hyper immune serum (O, A, C, SAT1, SAT2, 
SAT3, Asia1) diluted in coating buffer (rows A-H 
receives). The plates were covered with tight fitting 
lid, kept overnight at 4°C, then the plates were washed 
by washing buffer 3 times and dried.
Blocking
The coated plates were blocked by adding 
100  μl/well of blocking buffer (phosphate-buffered 
saline [PBS] buffer with 2-3% bovine serum albumin) 
and incubated at 37°C/1 h on a rotatory shaker then 
the plates washed and dried as before.
Addition of samples
Prepare tested sample suspension (10% original 
sample suspension) 50 μl were transferred to each 
well of the ELISA plate, two well were used for each 
sample and incubated at 37°C for 1 h. Then the plates 
washed and dried as before.
Addition guinea pigs hyper immune serum (GPHIS)
A volume of 50 μl of GPHIS for each serotypes 
O, A, C, SAT1, SAT2, SAT3 and Asia 1 were added in 
well from A to H and incubated at 37°C/1 h then the 
plates were washed and dried.
Addition of conjugate
A volume of 50 μl of anti guinea pigs conjugate 
were added in every well and plates were incubated at 
37°C for 1 h.
Addition of substrate/chromogen
50 μl of outpatient department/H2O2 (freshly pre-
pared) added to each well and the plates kept in dark 
place for 15 min.
Stopping solutions
The reaction was stopped by adding 25 μl of 
1.25 M of H2SO4 to every well.
Interpretation of results
Color reaction on adding the enzyme substrate 
and chromogen indicated positive reaction. With 
strong positive reactions, this will be evident to the 
naked eye, but results can also be read spectrophoto-
metrically at 492 nm on ELISA reader.Available at www.veterinaryworld.org/Vol.7/October-2014/25.pdf
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Corrected OD values of control positive=Mean 
OD value of control positive − Mean OD value of 
control negative.
It must be >0.1 to accept the test result.
Corrected OD values of test samples =Mean OD 
value of sample − Mean OD value of control negative.
Sample demonstrating corrected OD value >0.1 
considered positive.
RNA extraction and RT-PCR
RNA was extracted from samples using the 
QIAamp® Viral RNA kits (Qiagen, Germany) according 
to the manufacture’s protocol. Primer pair (PoR/PoF) 
for FMDV RNA detection was used. PoF (5´- CCT 
ATG AGA ACA AGC GCA TC -3´) and PoR (5´- CAA 
CTT CTC CTG TAT GGT CC -3´) were derived from 
the virus 3D polymerase to amplify 422 bp expected 
target sequence [28]. All positive samples to FMDV 
specific primers were further investigated against SAT 
serotypes specific oligos to give 715-730 bp expected 
band sizes for the RT-PCR products [29].
Extracted RNA were examined using OneStep 
RT-PCR kit (Qiagen, Germany). The reaction was 
done in 50 μl reaction volum, containing 10 μl RNA 
template and 0.6 μM from each primer. The cycling 
parameters were 50°C for 30 min and 95°C for 15 min; 
then 30 cycles consisting of 94°C for 45s, 55°C for 
45s and 72°C for 60s positive controls and negative 
controls were involved in most runs.
Serology
SNT
The test was performed by the microtechnique as 
described by Ferreira [30] in flat bottom tissue culture 
microtite plates. Two-fold serially diluted sera in mod-
ified Eagle’s medium were used. From each dilution, 
50 μl serum samples were added in every well (dupli-
cated, two-fold dilution series of each tested serum).
Then 50 μl containing 100 TCID50 FMDV (pre-
viously titrated), were added to each well. The plates 
were putted on microshaker for 10 s. then incubated at 
37°C in CO2 incubator for 1 h to allow neutralization, 
then 150 μl of BHK-21 cells suspension were added 
to each well. The plates were incubated at 37°C in 
CO2 incubator for 48 h and the wells were examined 
microscopically for the presence of CPE as calculated 
by Reed et al. [24].
For staining of the SNT microplates, discarded 
the media, and the cell cultures were stained by 1% 
crystal violet stain for 30 min after which excess stain 
was discarded, the plates were washed with distilled 
water for at least 5 times and left for 30 min to dry in 
the incubator.
Indirect enzyme linked immunosrobent assay (ELISA)
50 μl/well of FMD SAT2 antigen was diluted 
in coating buffer, added to ELISA plates and left on 
micro-shaker over night at 4°C.
The plates were washed 3 times with washing 
buffer Rto remove excess FMD antigen,blocked with 
100 μl/well PBS containg 2% bovine albumin and 
incubated at 37°C for 1 h, then was washed 3 times by 
washing buffer and dried.
Add 50 μl of each sample serum (two well/sam-
ple) then incubate 1 h at 37°C, and washing 3 times by 
washing buffer and dry.
Add 50 μl/well of the optimum dilution of horse-
radish peroxidase conjugated, then incubate at 37°C 
for 1 h and washing 3 times by washing buffer and 
dry.
Incubate with 50 μl/well substrate solution for 
10-15 min in dark place.
Stop incubation by adding 50 μl/well of 1.25 M 
sulforic acid.
Read results at 492 nm of ELISA reader.
(N.B. positive and negative reference control 
sera include reagent control everything except sam-
ple). The control positive must be known cut off titer 
in case for calculation that mean.
ELISA reading=
OD of unknown sample
OD of positive control se erum (cut off)
The result may be 1.0 or more than 1.0 or <1.0.
Ratio 1.0 or more means positive, <1.0 means 
negative, cut off of FMD (positive control serum dilu-
tion) is 0.9 according to Eu-FMD [31].
Results and Discussion
The present work confirmed that buffalo cow at 
location A were naturally infected with FMDV. The 
observed mouth lesions consisted of 35 (70%) tongue 
lesions; 44 (88%) bucal mucosal lesions. The number 
of lesions recorded for the right and left for limbs were 
39 (78%) and 34 (68%) respectively, and those for the 
right and left hind limbs were 36 (72%) and 23 (46%) 
accordingly (Table-1). These findings agree with the 
specific FMD signs as stated by Depa et al. [3].
The causative organism of the observed 
lesion was confirmed to be FMDV serotype SAT2. 
Inoculation of baby mice resulted in paralysis of the 
hind limbs followed by death (Figure-1), and infec-
tion of BHK cells showed characteristic CPE of cell 
rounding and monolayer detachment within 24 h post 
infection (Figures-2 and 3). The isolate was confirmed 
as FMDV serotype SAT2 using CFT; ELISA and PCR 
(Table-1). The use of such techniques for isolation; 
identification and typing of FMDV were recom-
mended by [26,28,10].
Regarding the induced FMD antibodies in vac-
cinated and naturally infected buffalo cows, Table-2 
showed that either vaccinated or infected animals 
exhibited detectable FMD type SAT2 antibodies in 
the 1st week post vaccination (1.05 and 1.34 by SNT 
and ELISA respectively) or infection (2.1 and 2.35 
by SNT and ELISA respectively), and peaked by the 
12th week latter (2.5 and 2.81 by SNT and ELISA 
respectively) and 3rd week (2.7 and 3 by SNT and 
ELISA respectively) in vaccinated and infected ani-
mals respectively. These titers began to decline to Available at www.veterinaryworld.org/Vol.7/October-2014/25.pdf
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reach their lowest protective levels (1.5 and 1.8 by 
SNT and ELISA respectively) at 32 week post vac-
cination in vaccinate and (1.65 and 1.82 by SNT and 
ELISA respectively) at 36th week post infection in 
infected animals. These findings come in agreement 
with [11-13] they reported that the antibody response 
in cattle experimentally infected with FMDV per-
sisted for 40 weeks and the highest antibody titer was 
reached on 10 days post infection, while the serum 
neutralizing antibodies reached their highest titers 
within 7-10 days after infection of cattle with type 
“O” FMDV. The results also showed that the recorded 
antibody level remained protective for 4 months.
Previous works [19,20] showed that the mean 
protective serum antibody titers against FMD in calves 
vaccinated with double oil emulsion (Montanide ISA 
206) as evaluated by ELISA and SNT were detected 
on the 3rd week post vaccination reached their highest 
level on the 10th week, remained protective untill the 
Table-1: Clinical signs; isolation and identification of FMDV from naturally infected pregnant buffalo.
Number 
of animals
Clinical Signs in Isolation and identification in
Mouth Limbs TE and BM OP
T BM FL HL By application on
RLRL T C Baby mice ELISA PCR TC Baby mice ELISA PCR
50 35 44 39 34 36 38 35 43 SAT2 41 46 SAT2
% 70 88 78 68 72 76 70 86 100 82 92 100
T=Toung, TE=Toung epithelium, BM=Buccal mucosa, FL=Fore limb, HL=Hind limb, R=Right, L=Left, TC=Tissue culture, 
OP=Esophageal propping, FMDV=Foot and mouth disease virus
Table-2: Mean FMD (SAT2) antibody titers in sera of 
vaccinated and infected buffalo by SNT and ELISA.
Weeks post 
vaccination 
or infection
Mean FMD (SAT2) antibody 
titers (log10/ml) in
Vaccinated 
buffalo
Naturally 
infected 
buffalo
SNT ELISA SNT ELISA
0 0000
1 1.05 1.34 2.1 2.35
2 1.35 1.68 2.5 2.73
3 1.68 1.99 2.7 3
4 1.77 2.01 2.7 2.95
6 1.86 2.1 2.7 2.9
8 1.95 2.28 2.6 2.76
10 2.02 2.36 2.55 2.8
12 2.5 2.81 2.4 2.75
16 2.3 2.54 2.3 2.54
20 2.2 2.42 2.1 2.35
24 1.85 1.99 1.95 2.13
28 1.7 1.87 1.85 2.09
32 1.5 1.8 1.72 1.9
36 1.3 1.7 1.65 1.82
40 1.1 1.35 1.4 1.62
SNT=Serum neutralisation test, FMD=Foot and mouth 
disease, ELISA=Enzyme linked immunosrobent assay.
Protective level of SNT=1.5 , ELISA 1.8
Figure-1: Paralysis in hind limb of baby mice inoculated 
with suspected Op samples (Positive results of presence of 
FMDV in samples). 
Figure-2: Unstained BHK cell inoculated with suspected 
Op samples showing rounding CPE in cell (Positive results 
of presence of FMDV in samples). 
Figure-3: Stained BHK cell inoculated with suspected Op 
samples showing rounding CPE in cell (Positive results of 
presence of FMDV in samples).Available at www.veterinaryworld.org/Vol.7/October-2014/25.pdf
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32nd week post vaccination, and then started to decline 
below protective levels for both FMDV serotypes.
In the current study, FMD type SAT2 antibodies 
in all calves born to vaccinated and infected buffalo 
cows, were detected on the 1st day post parturition, 
with antibody titers of (1.95 and 2.24 by SNT and 
ELISA respectively, and (2.06 and 2.34 by SNT and 
ELISA respectively) from vaccinated and infected 
dams accordingly (Table-3). The highest mater-
nal derived FMDV type SAT2 antibody titers were 
recorded by the 2nd day of age (2.3 and 2.6 by SNT and 
ELISA respectively in calves from vaccinated dams 
and 2.4 and 2.62 by SNT and ELISA respectively in 
calves from infected dams). These antibodies declined 
to the lowest protective titer at 14th weeks 1.5 and 1.82 
by SNT and ELISA respectively in calves from vac-
cinated dams and at 16 weeks 1.5 and 1.83 by SNT 
and ELISA respectively in calves from infected dams. 
Comparable results were obtained by other research-
ers [17], where they observed that antibody titers in 
sera of kids born to goats vaccinated with FMD vac-
cine at 3 months of gestation were high for day old 
kids after feeding on colostrum and remained at pro-
tective level until 45-60 day of age.
Table-4 demonstrates the FMDV type SAT2 anti-
body titers in the colostrum and milk samples of vac-
cinated and naturally infected buffalo cows, revealing 
the highest titers were (2.5 and 2.75 by SNT and ELISA 
respectively in vaccinated buffalo and 2.8 and 3.05 by 
SNT and ELISA respectively, in infected buffalo cow at 
parturition). The lowest protective levels were (1.5 and 
1.8 by SNT and ELISA respectively, in vaccinated 
buffalo at 10 wpp and 1.5 and 1.8 by SNT and ELISA 
respectively, in infected buffalo) at 12nd wpp. Similar 
findings were recorded by El-Shehawy et al. [16,18] 
they mentioned that FMD antibody titers in colostrum 
and milk from experimentally infected pregnant ewes 
started high at the 1st day post partum as 2.52 and 2.82 
by SNT and ELISA respectively.
Calves sera before feeding on colostrum of vac-
cinated or naturally infected buffalos were free from 
antibody where titers were zero either by SNT and 
ELISA, but at parturition, colostrum from vaccinated 
buffalo showed the highest level of antibodies than 
vaccinated buffalo and their calves. Mean titers were 
log10 (2.5, 1.95 and zero) respectively by SNT while 
mean titers were log10 (2.78, 2.28 and zero) respec-
tively by ELISA. One DPP and feeding on colos-
trum, calves sera titers were log10 (1.95 and 2.24) by 
SNT and ELISA respectively while antibody titers 
in buffalo serum were log10 (1.95 and 2.28) by SNT 
and ELISA respectively as shown in Figures-4 and 5. 
Mean protective levels of antibodies in calves started 
at the first DDP and remain protective up to 14th WPP 
while in vaccinated buffalos antibody titers were 
remain in protective level up to 32nd WPP.
Colostrum from infected buffalo showed the 
highest level of antibodies than infected buffalo and 
their calves. Mean titers were log10 (2.8, 2.45 and 
zero) respectively by SNT while mean titers were 
log10 (3.05, 2.73 and zero) respectively by ELISA. One 
DPP and feeding on colostrum, calves sera titers were 
log10 (2.06 and 2.34) by SNT and ELISA respectively 
while antibody titers in infected buffalo serum were 
log10 (2.45 and 2.73) by SNT and ELISA respectively 
as shown in Figures-6 and 7. Mean protective levels 
of antibodies in calves started at the first DDP and 
remain protective up to 16th WPP while in naturally 
Table-3: Monitoring the mean FMD (SAT2) antibody titers 
in sera of buffalo calves born to vaccinated and infected 
buffalo cows.
Time of 
testing
Mean FMD (SAT2) antibody 
titers (log10/ml) in
Calves from 
vaccinated 
buffalo
Calves from 
naturally 
infected 
buffalo
SNT ELISA SNT ELISA
At parturition 0000
1DPP* 1.95 2.24 2.06 2.34
2DPP 2.3 2.6 2.4 2.62
3DPP 2.2 2.5 2.3 2.57
4DPP 2.06 2.26 2.1 2.36
2WPP** 1.95 2.2 2 2.28
4WPP 1.86 2.12 1.9 2.15
6WPP 1.74 2 1.95 2.24
8WPP 1.7 1.95 1.89 2.19
10WPP 1.65 1.9 1.8 2.13
12WPP 1.54 1.87 1.7 2.05
14WPP 1.5 1.82 1.62 1.97
16WPP 1.4 1.8 1.5 1.83
18WPP 1.2 1.6 1.3 1.74
20WPP 0.9 1.2 1.2 1.5
*DPP=Days post parturition, **WPP=Week post parturition,
FMD=Foot and mouth disease, SNT=Serum neutralization 
test, ELISA: Enzyme linked immunosorbent assay.
Protective level of SNT=1.5, ELISA 1.8
Table-4: Tracing of the mean FMD (SAT2) antibody titers 
of colostrum and milk of buffalo cows.
Time of 
testing
Mean FMD (SAT2) antibody titers 
(log10/ml) in colostrum and milk of
Vaccinated 
buffalo
Naturally 
infected 
buffalo
SNT ELISA SNT ELISA
At parturition 2.5 2.75 2.8 3.05
1DPP* 2.4 2.7 2.65 2.9
2DPP 2.4 2.65 2.6 2.84
3DPP 2.35 2.55 2.5 2.7
4DPP 2.3 2.5 2.35 2.61
2WPP** 2.05 2.35 2.1 2.35
4WPP 1.8 2.1 1.95 2.15
6WPP 1.65 1.95 1.8 2.01
8WPP 1.5 1.85 1.65 1.95
10WPP 1.5 1.8 1.5 1.85
12WPP 1.3 1.6 1.5 1.8
14WPP 1.2 1.48 1.4 1.74
*DPP=Days post parturition, **WPP=Week post parturition,
FMD=Foot and mouth disease, ELISA=Enzyme linked 
immunosorbent assay, SNT=Serum neutralization test.
Protective level of SNT=1.5, ELISA 1.8Available at www.veterinaryworld.org/Vol.7/October-2014/25.pdf
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infected buffalos antibody titers were remain in pro-
tective level up to 36th WPP.
Conclusion
The causative agent of the observed FMD signs 
in pregnant buffalo at El-Fayoum Governorate was 
FMDV type SAT2, which may have been intro-
duced to the farm through aerosols from imported 
animals in nearby farms. In addition, naturally 
infected and vaccinated buffalos were able to 
provide their calves with high levels of maternal 
immunity derived antibodies through their colos-
trum and milk, which could protect newly born 
calves against identical FMDV serotypes SAT2 or 
not <3 months of age.
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Figure-4: Comparison between the mean antibody titer 
of serum and colostrum of naturally infected buffalo, their 
calves by serum neutralization test.
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Figure 5: Comparison between the mean antibody titer 
of serum and colostrum of naturally infected buffalo, their 
calves by enzyme linked immunosrobent assay.
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Figure 6: Comparison between the mean antibody titer of 
serum and colostrum of vaccinated buffalo, their calves by 
serum neutralization test.
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Figure 7: Comparison between the mean antibody titer of 
serum and colostrum of vaccinated buffalo, their calves by 
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